Which returned more over the last year, IBB or XOP?

In the year to Sep 12, 2026, with distributions reinvested, IBB returned +41.5% and XOP returned +52.4%, so XOP returned more. One year is one year; the longer windows are in the table.

Which is cheaper, IBB or XOP?

IBB charges 0.44% a year and XOP charges 0.35%, so XOP is cheaper. Fees come from each fund's prospectus.

Data as of Sep 12, 2026. Both funds on the fields they both publish, from the same sources.

ETFIQetfiq.com · independent ETF data

IBB vs XOP: how they differ

IBB and XOP hold 0% of their weight in the same names, and XOP returned more over the year.

iShares Biotechnology ETF and State Street(R) SPDR(R) S&P(R) Oil & Gas Exploration & Production ETF.

What they hold in common

By the books each fund has filed, IBB and XOP hold 0% of their money in the same securities at the same weight.

Largest positions each one holds and the other does not
Only in IBB	Only in XOP
Vertex Pharmaceuticals, Inc. 8.09%	Texas Pacific Land Corp 3.17%
Amgen, Inc. 7.84%	PBF Energy Inc 2.91%
Gilead Sciences, Inc. 6.85%	Delek US Holdings Inc 2.81%
Regeneron Pharmaceuticals, Inc. 4.91%	Expand Energy Corp 2.80%
Argenx SE 3.76%	CNX Resources Corp 2.78%
Alnylam Pharmaceuticals, Inc. 3.12%	EQT Corp 2.75%
Natera, Inc. 2.89%	Valero Energy Corp 2.75%
Revolution Medicines, Inc. 2.78%	Antero Resources Corp 2.68%

Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed. Above 50%, holding both is close to holding one of them twice. Holdings dated Jun 30, 2026.

IBB and XOP on the fields both publish, as of Sep 12, 2026. Source: ETFIQ.
	IBB iShares Biotechnology ETF	XOP State Street(R) SPDR(R) S&P(R) Oil & Gas Exploration & Production ETF
Where it sits	Core index fund	Core index fund
Issuer	iShares	State Street
What it is	Biotechnology	SPDR S&P Oil & Gas Exploration & Production
Total return, 1 year	+41.5%	+52.4%
S&P 500 over the same days	+17.5%	+17.5%
Gap to the S&P 500	+24.0 pts	+34.9 pts
Expense ratio	0.44%	0.35%
Holdings	248	51

IBB in plain words

IBB is an index equity fund tracking the Biotechnology. Over the year to Sep 11, 2026 it returned +41.5% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.44% a year. By its holdings filed for Jun 30, 2026, 36% of the fund by weight is stocks the S&P 500 also holds, across 248 positions, with the top ten at 44.8%. It sat 6.5% below its high of Aug 19, 2026 on Sep 11, 2026.

XOP in plain words

XOP is a commodity fund tracking the SPDR S&P Oil & Gas Exploration & Production. Over the year to Sep 11, 2026 it returned +52.4% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.35% a year. It sat 26.8% below its high of Jun 23, 2014 on Sep 11, 2026.

Questions people ask

Which returned more over the last year, IBB or XOP?: In the year to Sep 12, 2026, with distributions reinvested, IBB returned +41.5% and XOP returned +52.4%, so XOP returned more. One year is one year; the longer windows are in the table.
Which is cheaper, IBB or XOP?: IBB charges 0.44% a year and XOP charges 0.35%, so XOP is cheaper. Fees come from each fund's prospectus.

Other comparisons

Where to next

Where these figures came from

ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.

IBB against XOP, ETFIQ, data as of Sep 12, 2026. Every figure is arithmetic on a named public source; the method is at etfiq.com/methodology. A comparison is not a recommendation.

Cite this page. ETFIQ, IBB against XOP, data as of Sep 12, 2026. https://etfiq.com/compare/any/IBB-XOP Free to use with attribution; the underlying files are at Open data.

A comparison is not a recommendation. Standards and sources